Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pons

Showing results (381-390 of 394) with videos related to

Pageof 40
Sort By:
Arthritis Care & Research|December 28, 2021
Evaluating the Construct of Damage in Systemic Lupus ErythematosusSindhu R Johnson, Dafna D Gladman, Hermine I Brunner, et al.
Lupus|July 2, 2020
Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohortRosana Quintana, Guillermo J Pons-Estel, Karen Roberts, et al.
Seminars in Arthritis and Rheumatism|August 6, 2024
OMERACT systemic lupus erythematosus domain surveyWils Nielsen, Vibeke Strand, Lee Simon, et al.
International Journal of Rheumatic Diseases|April 13, 2026
Cross Cultural Validation of Work Productivity and Activity Impairment Questionnaire in Lupus Patients From Latin AmericaRomina E Nieto, Lucia Hernández, Rosana Quintana, et al.
Lupus|January 29, 2021
A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study GroupJosé A Gómez-Puerta, Guillermo J Pons-Estel, Rosana Quintana, et al.
Annals of the Rheumatic Diseases|February 17, 2022
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology AllianceManuel Francisco Ugarte-Gil, Graciela S Alarcón, Zara Izadi, et al.
Clinical Rheumatology|October 6, 2022
Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID RegistryCarolina A Isnardi, Karen Roberts, Verónica Saurit, et al.
Seminars in Arthritis and Rheumatism|March 8, 2025
Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome setWils Nielsen, Fadi Kharouf, Carolina Munoz Grajales, et al.
Annals of the Rheumatic Diseases|May 29, 2021
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registryJeffrey A Sparks, Zachary S Wallace, Andrea M Seet, et al.
Lupus Science & Medicine|April 20, 2026
Baseline characteristics of patients with SLE with and without lupus nephritis from the Latin American multiethnic GLADEL 2.0 cohortGuillermo J Pons-Estel, Romina E Nieto, Rosana Quintana, et al.
Pageof 40

Showing results (381-390 of 394) with videos related to

Sort By:
Pageof 40
Arthritis Care & Research|December 28, 2021
Evaluating the Construct of Damage in Systemic Lupus ErythematosusSindhu R Johnson, Dafna D Gladman, Hermine I Brunner, et al.
Lupus|July 2, 2020
Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohortRosana Quintana, Guillermo J Pons-Estel, Karen Roberts, et al.
Seminars in Arthritis and Rheumatism|August 6, 2024
OMERACT systemic lupus erythematosus domain surveyWils Nielsen, Vibeke Strand, Lee Simon, et al.
International Journal of Rheumatic Diseases|April 13, 2026
Cross Cultural Validation of Work Productivity and Activity Impairment Questionnaire in Lupus Patients From Latin AmericaRomina E Nieto, Lucia Hernández, Rosana Quintana, et al.
Lupus|January 29, 2021
A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study GroupJosé A Gómez-Puerta, Guillermo J Pons-Estel, Rosana Quintana, et al.
Annals of the Rheumatic Diseases|February 17, 2022
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology AllianceManuel Francisco Ugarte-Gil, Graciela S Alarcón, Zara Izadi, et al.
Clinical Rheumatology|October 6, 2022
Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID RegistryCarolina A Isnardi, Karen Roberts, Verónica Saurit, et al.
Seminars in Arthritis and Rheumatism|March 8, 2025
Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome setWils Nielsen, Fadi Kharouf, Carolina Munoz Grajales, et al.
Annals of the Rheumatic Diseases|May 29, 2021
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registryJeffrey A Sparks, Zachary S Wallace, Andrea M Seet, et al.
Lupus Science & Medicine|April 20, 2026
Baseline characteristics of patients with SLE with and without lupus nephritis from the Latin American multiethnic GLADEL 2.0 cohortGuillermo J Pons-Estel, Romina E Nieto, Rosana Quintana, et al.
Pageof 40